Cytosorbents (CTSO) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CTSO Hot Sheet
Join SI Premium – FREE
Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.9 million versus the consensus estimate of $9.23 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
- Amrize Ltd (AMRZ:SW) (AMRZ) PT Lowered to CHF46 at Deutsche Bank
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
